
SaMD 510k Process
Achieving FDA 510(k) clearance for Software as a Medical Device (SaMD) requires a clear, structured approach that demonstrates your software’s safety, performance, and substantial equivalence to a legally marketed device. This page outlines our comprehensive SaMD 510k process including regulatory strategy, risk classification, software documentation, cybersecurity validation, and submission preparation, ensuring manufacturers understand each step from initial planning to FDA clearance. With our proven expertise in SaMD regulatory pathways, we help developers navigate complex FDA expectations and achieve a smooth, efficient approval journey.
FDA 510k for Software as a Medical Device
Obtaining FDA 510(k) clearance for Software as a Medical Device (SaMD) can be a demanding and highly detailed process. Successfully navigating this pathway calls for precise documentation, strong technical justification, and a clear understanding of FDA expectations.
Software as a Medical Device 510k Process
|
Phase 1 – Initial Details |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
| 1.1 | Intended use |
|
|
| 1.2 | Indication s of Use Statement (Form 3881) |
|
|
| 1.3 | software medical Device Description |
|
|
| 1.4 | Predicate Device |
|
|
| 1.5 | 510(K) Summary |
|
|
| 1.6 | Software |
|
|
|
Phase 2 – Software Supporting Documentation based on Level of Concern |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
| 2.1 | Proposed SaMD Labelling |
|
|
| 2.2 | Software Device Description |
|
|
| 2.3 | System and Software Architecture |
|
– the modules and layers that make up the system and software |
| 2.4 | Software Requirement Specifications |
|
Minor Level of concern: Summary of functional requirements from SRS. Moderate and Major:
– inputs and outputs |
| 2.5 | Software Design Specifications |
|
Minor Level of Concern: No documentation is required. Moderate and Major Level of Concern:
Details to be included are: |
| 2.6 | Software Development and Maintenance Practices |
|
Minor Level of Concern: No documentation is required. Major and Moderate level of Concern:
OR Moderate level of concern:
Major Level of concern:
|
| 2.7 | Software testing as part of verification and validation |
|
Minor Level of Concern: System level test plan, including pass/fail criteria and results. Moderate Level of concern:
Major Level of concern:
|
| 2.8 | Risk Management File |
|
|
| 2.9 | Revision History |
|
|
| 2.10 | Unresolved Anomalies |
|
Minor Level of Concern:
Moderate and Major Level of Concern:
|
| 2.11 | Hardware Requirements |
|
|
| 2.12 | Software Compliance Documents and Certificates |
|
|
|
Phase 3 – Substantial Equivalence and Executive Summary |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
| 3.1 | Executive Summary |
|
NIL |
| 3.2 | Substantial Equivalence Discussion |
|
NIL |
|
Phase 4 – Administrative Documents |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
| 4.1 | 510(k) Cover Letter |
|
|
| 4.2 | Truthful and Accuracy Statement |
|
|
| 4.3 | Declarations of conformity and Summary report |
|
|
| 4.4 | MDFUSC (FDA Form 3601) |
|
|
|
Phase 5 – Pre STAR Submission (PreSubmission/Q-Submission) |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
| 5.1 |
Q-Submission (optional) Recommended prior to testing
|
Tracking of the review process and interacting with the US FDA reviewer throughout the review process. |
Confirm the Questions framed. Share the test plans and device details |
|
Phase 6 – eSTAR Submission (Final 510(k) Submission) |
|||
|
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
|
6.1 |
eSTAR Preparation |
Populate and validate the eSTAR’s latest version template with all required sections, attachments and rationale (if any) |
Confirm and approve the Final Submission folder prior to eSTAR packaging. |
|
6.2 |
eSTAR Submission |
Verify successful submission and share FDA acknowledgment |
Provide any additional details if FDA issues RTA comments — RTA typically occurs due to user fee issues such as fee not received because of missing transaction charges or insufficient payment amount |
